Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Oct-22 8:23 PM View:  | Stock Elyse Chief Medical Officer | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 5,374 | $148.50 | $798,039.00 | (100%) 5.37K to 0 | |
| 03-Oct-22 8:23 PM View: | Conway Charles Chief Scientific Officer | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 22,362 | $148.50 | $3,320,760.00 | (100%) 22.36K to 0 | |
| 03-Oct-22 8:29 PM View: | Childs John W Director | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 3,025,000 | $148.50 | $449,212,992.00 | (100%) 3.04M to 10.0K | |
| 03-Oct-22 8:27 PM View: | Tilton John Chief Commercial Officer | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 1,614 | $148.50 | $239,679.00 | (50%) 3.23K to 1.61K | |
| 03-Oct-22 8:28 PM View: | Buten Matthew Chief Financial Officer | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 6,177 | $148.50 | $917,284.00 | (100%) 6.18K to 0 | |
| 03-Oct-22 8:30 PM View: | Engelhart James Strategic Advisor | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 15,900 | $148.50 | $2,361,150.00 | (100%) 15.9K to 0 | |
| 03-Oct-22 8:25 PM View: | Jones William A Jr CCO-Migraine & Common Disease | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 14,226 | $148.50 | $2,112,560.00 | (100%) 14.23K to 0 | |
| 03-Oct-22 8:24 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 4,292 | $148.50 | $637,362.00 | (100%) 4.29K to 0 | |
| 03-Oct-22 8:20 PM View: | Gentile Kimberly SVP, Clinical Operations | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 11,653 | $148.50 | $1,730,470.00 | (100%) 11.65K to 0 | |
| 03-Oct-22 8:29 PM View: | Childs John W Director | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 10,000 | $148.50 | $1,485,000.00 | (100%) 10.0K to 0 | |
| 03-Oct-22 8:25 PM View: | Hugin Robert J Director | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 2,900 | $148.50 | $430,650.00 | (100%) 2.9K to 0 | |
| 03-Oct-22 8:26 PM View: | Coric Vlad Chief Executive Officer Director | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 92,050 | $148.50 | $13,669,400.00 | (3%) 2.77M to 2.68M | |
| 03-Oct-22 8:27 PM View: | Mehta Kishan Director | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 10,640 | $148.50 | $1,580,040.00 | (100%) 10.64K to 0 | |
| 03-Oct-22 8:23 PM View: | Stock Elyse Chief Medical Officer | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 11,090 | $148.50 | $1,646,860.00 | (67%) 16.46K to 5.37K | |
| 03-Oct-22 8:23 PM View: | Bailey Gregory Director | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 2,583,660 | $148.50 | $383,672,992.00 | (100%) 2.58M to 0 | |
| 03-Oct-22 8:27 PM View: | Tilton John Chief Commercial Officer | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 5,068 | $148.50 | $752,598.00 | (61%) 8.3K to 3.23K | |
| 03-Oct-22 8:26 PM View: | Coric Vlad Chief Executive Officer Director | Biohaven Pharmaceutical Hol... (BHVN) | 03-Oct-22 | Disposition | 830,891 | $148.50 | $123,387,000.00 | (31%) 2.68M to 1.85M | |
| 22-Aug-22 7:00 PM View: | Bailey Gregory Director | Biohaven Pharmaceutical Hol... (BHVN) | 19-Aug-22 | Purchase | 38,000 | $148.04 | $5,625,680.00 | 1% 2.55M to 2.58M | |
| 12-May-22 8:58 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 10-May-22 | Option Exercise | 2,250 | $53.76 | $120,960.00 | 37% 6.01K to 8.27K | |
| 12-May-22 8:58 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 10-May-22 | Planned Option Sale | 2,250 | $141.50 | $318,375.00 | (27%) 8.27K to 6.01K | |
| 12-May-22 8:58 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 10-May-22 | Sale (Planned) | 1,950 | $141.50 | $275,925.00 | (32%) 6.01K to 4.07K | |
| 24-Jan-22 6:01 AM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 19-Jan-22 | Sale (Planned) | 3,705 | $117.01 | $433,536.00 | (38%) 9.72K to 6.01K | |
| 24-Jan-22 6:01 AM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 19-Jan-22 | Option Exercise | 5,670 | $46.53 | $263,846.00 | 58% 9.72K to 15.39K | |
| 24-Jan-22 6:01 AM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 19-Jan-22 | Planned Option Sale | 5,670 | $117.01 | $663,468.00 | (37%) 15.39K to 9.72K | |
| 12-Jan-22 9:04 PM View: | Mehta Kishan Director | Biohaven Pharmaceutical Hol... (BHVN) | 10-Jan-22 | Option Exercise | 1,875 | -- | -- | 21% 8.77K to 10.64K | |
| 12-Jan-22 9:12 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 10-Jan-22 | Option Exercise | 1,000 | -- | -- | 11% 9.18K to 10.18K | |
| 12-Jan-22 9:10 PM View: | Stock Elyse Chief Medical Officer | Biohaven Pharmaceutical Hol... (BHVN) | 10-Jan-22 | Option Exercise | 937 | -- | -- | 6% 15.53K to 16.46K | |
| 12-Jan-22 9:12 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 10-Jan-22 | Payment of Exercise | 464 | $128.87 | $59,795.70 | (5%) 10.18K to 9.72K | |
| 07-Jan-22 9:16 PM View: | Coric Vlad Chief Executive Officer Director | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Payment of Exercise | 4,634 | $128.87 | $597,184.00 | (< 1%) 962.35K to 957.71K | |
| 07-Jan-22 9:18 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Option Exercise | 1,000 | -- | -- | 11% 8.71K to 9.71K | |
| 07-Jan-22 9:17 PM View: | Stock Elyse Chief Medical Officer | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Payment of Exercise | 1,539 | $128.87 | $198,331.00 | (9%) 17.07K to 15.53K | |
| 07-Jan-22 9:17 PM View: | Stock Elyse Chief Medical Officer | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Option Exercise Duplicate | 1,000 | -- | -- | 6% 16.07K to 17.07K | |
| 07-Jan-22 9:16 PM View: | Jones William A Jr CCO-Migraine & Common Disease | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Payment of Exercise | 1,631 | $128.87 | $210,187.00 | (10%) 15.63K to 14.0K | |
| 07-Jan-22 9:18 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Payment of Exercise | 522 | $128.87 | $67,270.10 | (5%) 9.71K to 9.18K | |
| 07-Jan-22 9:17 PM View: | Engelhart James Strategic Advisor | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Option Exercise | 3,250 | -- | -- | 24% 13.7K to 16.95K | |
| 07-Jan-22 9:16 PM View: | Jones William A Jr CCO-Migraine & Common Disease | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Option Exercise | 3,750 | -- | -- | 32% 11.88K to 15.63K | |
| 07-Jan-22 9:16 PM View: | Coric Vlad Chief Executive Officer Director | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Option Exercise | 10,000 | -- | -- | 1% 952.35K to 962.35K | |
| 07-Jan-22 9:18 PM View: | Tilton John Chief Commercial Officer | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Payment of Exercise | 342 | $128.87 | $44,073.50 | (5%) 6.89K to 6.55K | |
| 07-Jan-22 9:17 PM View: | Engelhart James Strategic Advisor | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Payment of Exercise | 1,279 | $128.87 | $164,825.00 | (8%) 16.95K to 15.67K | |
| 07-Jan-22 9:17 PM View: | Stock Elyse Chief Medical Officer | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Option Exercise | 3,250 | -- | -- | 25% 12.82K to 16.07K | |
| 07-Jan-22 9:18 PM View: | Tilton John Chief Commercial Officer | Biohaven Pharmaceutical Hol... (BHVN) | 07-Jan-22 | Option Exercise | 875 | -- | -- | 15% 6.02K to 6.89K | |
| 07-Jan-22 9:16 PM View: | Jones William A Jr CCO-Migraine & Common Disease | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Payment of Exercise | 2,230 | $123.86 | $276,208.00 | (16%) 14.11K to 11.88K | |
| 07-Jan-22 9:18 PM View: | Clark George C. VP, Chief Accounting Officer | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Payment of Exercise | 409 | $123.86 | $50,658.70 | (4%) 9.12K to 8.71K | |
| 07-Jan-22 9:17 PM View: | Gentile Kimberly SVP, Clinical Operations | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Payment of Exercise | 1,800 | $123.86 | $222,948.00 | (13%) 13.45K to 11.65K | |
| 07-Jan-22 9:17 PM View: | Stock Elyse Chief Medical Officer | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Option Exercise | 3,750 | -- | -- | 39% 9.65K to 13.4K | |
| 07-Jan-22 9:17 PM View: | Engelhart James Strategic Advisor | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Option Exercise | 3,750 | -- | -- | 33% 11.48K to 15.23K | |
| 07-Jan-22 9:17 PM View: | Gentile Kimberly SVP, Clinical Operations | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Option Exercise | 3,750 | -- | -- | 39% 9.7K to 13.45K | |
| 07-Jan-22 9:16 PM View: | Jones William A Jr CCO-Migraine & Common Disease | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Option Exercise | 5,000 | -- | -- | 55% 9.11K to 14.11K | |
| 07-Jan-22 9:18 PM View: | Conway Charles Chief Scientific Officer | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Payment of Exercise | 1,800 | $123.86 | $222,948.00 | (8%) 23.93K to 22.14K | |
| 07-Jan-22 9:16 PM View: | Coric Vlad Chief Executive Officer Director | Biohaven Pharmaceutical Hol... (BHVN) | 06-Jan-22 | Option Exercise | 12,500 | -- | -- | 1% 945.7K to 958.2K |
